Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Assistance Publique Hopitaux De Paris
Assistance Publique Hopitaux De Paris ap hp
Assistance Publique Hopitaux De Paris aphp

Assistance Publique Hopitaux De Paris patents


Recent patent applications related to Assistance Publique Hopitaux De Paris. Assistance Publique Hopitaux De Paris is listed as an Agent/Assignee. Note: Assistance Publique Hopitaux De Paris may have other listings under different names/spellings. We're not affiliated with Assistance Publique Hopitaux De Paris, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Assistance Publique Hopitaux De Paris-related inventors


Treatment of a disease associated with retinal degenerative disorder

Treatment of a disease associated with retinal degenerative disorder. The present invention relates to human Transferrin or an active fragment thereof for use in the treatment of a disease associated with retinal degenerative disorder.... Assistance Publique Hopitaux De Paris

Method for treating cancer

The present invention relates to a method for preventing or treating cancer in an individual comprising administering the individual with a prophylactically or therapeutically effective quantity of a gingival fibroblast-derived product.... Assistance Publique Hopitaux De Paris

Methods for the treatment of leber congenital amaurosis

The present invention relates to a method for treating a Leber congenital amaurosis in a patient harbouring the mutation c.2991+1655 A>G in the CEP290 gene, comprising the step of administering to said patient at least one antisense oligonucleotide complementary to nucleic acid sequence that is necessary for preventing splicing of... Assistance Publique Hopitaux De Paris

Method of culturing segmented filamentous bacteria in vitro

The present invention relates to an in vitro method of culturing a segmented filamentous bacterium strain, comprising co-culturing said segmented filamentous bacterium strain with a eukaryotic host cell, wherein the culture is performed at an O2 level inferior to 5% in a rich tissue culture liquid medium containing bacterial medium... Assistance Publique Hopitaux De Paris

Coll2-1 peptide and its nitrated form as therapeutic targets for osteoarthritis treatment

The present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO2 peptide activity for use in the prevention and/or treatment of osteoarthritis. Further, the present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or... Assistance Publique Hopitaux De Paris

Use of low dose il-2 for treating autoimmune – related or inflammatory disorders

The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.... Assistance Publique Hopitaux De Paris

Combination of biomarkers for detecting and evaluating a hepatic fibrosis

optionally, at least one gene from among the list of the following sixteen genes: IL6ST, p14ARF, MMP9, ANGPT2, CXCL11, MMP2, MMP7, S100A4, TIMP1, CHI3L1, COL1A1, CXCL1, CXCL6, IHH, IRF9 and MMP1.... Assistance Publique Hopitaux De Paris

Levels of cxcl10/ip-10 forms and soluble cd26/dppiv activity as early predictive biomarkers for hiv/siv associated mucosal inflammation and progression towards aids

The invention provides methods for the identification of patients capable of controlling HIV progression, as well as to the identification of an antagonist form of IP-10 associated to HIV progression control and the uses thereof for improving the immunological response of HIV patients.... Assistance Publique Hopitaux De Paris

Method for transiently disrupting a region of the blood-brain barrier of a human

The present invention relates to a method for transiently disrupting a region of the blood-brain barrier (BBB) of a human using ultrasounds in the presence of an ultrasound contrast agent, and uses thereof. The method comprises the application of at least one ultrasound (US) beam with a pressure level higher... Assistance Publique Hopitaux De Paris

Method of analyzing the brain activity of a subject

The invention concerns a method of analysing the brain activity of a patient performing a given task or in response to an external stimulus, by comparison of standardized data with data in a database, by means of fuzzy logic algorithms.... Assistance Publique Hopitaux De Paris

Methods for the monitoring and prognosis of a cancer

The present invention relates to methods for prognosis and monitoring of a cancer, preferably bladder cancer, by measuring the proportion of CD8+ T Lymphocytes expressing ILT-2 and the plasma level of soluble HLA-G. The invention also relates to anti HLA-G antibodies for use for treating a cancer in which tumor... Assistance Publique Hopitaux De Paris

Predictive value of clostridium difficile-specific immune response for recurrence and disease outcome

The present invention relates to the field of Clostridium difficile infections. Methods of diagnosing, treating and preventing Clostridium difficile-associated disease and recurrent CDAD are disclosed herein.... Assistance Publique Hopitaux De Paris

Cyclic compounds having a 1,3 diamino-functionality for use in the treatment of hiv infection

The present invention relates to compounds, capable of activating HIV expression in reservoir cells, of formula (I) for use in the treatment of HIV infection.... Assistance Publique Hopitaux De Paris

Method for the continuous evaluation of the ventriculo-aortic coupling of at-risk patients by analysis of pressure-flow loops

The invention relates to the field of cardiovascular resuscitation and, more specifically, it concerns a novel method of monitoring the ventriculo-aortic coupling of at-risk patients on the basis of the aortic pressure/flow loop of the patient and the zoning of this loop.... Assistance Publique Hopitaux De Paris

Methods for predicting the outcome of a cancer in a patient by analysing gene expression

The present invention relates to a method for predicting the outcome of a cancer in a patient by analysing gene expression in a sample obtained from said patient. More particularly the present invention relates to a method for predicting the outcome of a cancer comprising a step consisting of determining... Assistance Publique Hopitaux De Paris

Synergistic combination of biomarkers for detecting and assessing hepatic fibrosis

The application relates to hepatic fibrosis, specifically to hepatic fibrosis that may appear in a patient infected with one or more hepatitis viruses and/or who is suffering from hepatitis, specifically chronic hepatitis. The application provides methods and means for determining the stage (or degree) of hepatic fibrosis of such a... Assistance Publique Hopitaux De Paris

Lauflumide and the enantiomers thereof, preparing same and therapeutic uses thereof

The invention relates to the molecule having formula (I), as well as the enantiomers thereof, and to the use of same in the treatment of ADHD, narcolepsy or idiopathic hypersomnia.... Assistance Publique Hopitaux De Paris

Removable implant for generating a tendon or a ligament

The present invention relates to a removable implant for generating a tendon or a ligament as a replacement for a torn tendon or ligament, said implant having a hollow tubular body (2) made of a biocompatible and non-resorbable material, with an internal lumen (3) delimited by a lateral wall (4)... Assistance Publique Hopitaux De Paris

Polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual

The present invention relates to the field of the in vitro diagnosis of the progression status of an infection of an individual with a virus belonging to the family of the Human Immunodeficiency Viruses (HIV) as well as with the therapeutical treatment of this infectious disease. The invention also relates... Assistance Publique Hopitaux De Paris

Methods for preventing and treating chronic kidney disease (ckd)

The present invention relates to methods for preventing and treating chronic kidney disease (CKD).... Assistance Publique Hopitaux De Paris

Detection of platelet-derived shed cd31

The present invention relates to various soluble forms of CD31, including a novel form which is shed by activated platelets and released into the circulation. Methods for detecting said soluble forms of CD31 are disclosed, as are methods of specifically 1 detecting said platelet-derived shed CD31 and the use of... Assistance Publique Hopitaux De Paris

Rapid detection of the "high virulent" st-17 clone of group b streptococcus

The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.... Assistance Publique Hopitaux De Paris

Compositions having means for targeting at least one antigen to dendritic cells

A composition that can be used as a vaccine containing means for targeting at least one antigen to dendritic cells and as adjuvants a granulocyte macrophage colony stimulating factor and a CpG oligodeoxynucleotide and/or a CpG-like oligodeoxynucleotide. This composition can used to treat cancers, infectious diseases caused by bacterial, viral,... Assistance Publique Hopitaux De Paris

Methods for the treatment of leber congenital amaurosis

The present invention relates to a method for treating a Leber congenital amaurosis in a patient harbouring the mutation c.2991+1655 A>G in the CEP290 gene, comprising the step of administering to said patient at least one antisense oligonucleotide complementary to nucleic acid sequence that is necessary for preventing splicing of... Assistance Publique Hopitaux De Paris

Combined vaccination/radioterapy for cancer treatment

Disclosed is a composition for use in the prevention or treatment of a subject suffering from a cancer in combination with radiotherapy, wherein the composition includes a conjugate, eventually associated with pharmaceutically acceptable carrier, the conjugate including i) the Shiga Toxin B subunit (STxB), a fragment or a derivative thereof;... Assistance Publique Hopitaux De Paris








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Assistance Publique Hopitaux De Paris in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Assistance Publique Hopitaux De Paris with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###